Rubicon Research R&D center in Ontario, Canada. image: rubicon.co.in Show Quick Read Summary is AI Generated. Newsroom Reviewed

Pharmaceutical formulation company Rubicon Research Ltd., which launched its initial public offering (IPO) on October 9, was booked 0.51 times on Thursday. Investors bid for 84,62,370 shares against the 1,64,55,670 shares on offer.

The company is looking to raise over Rs 1,000 crore from the primary market.

The grey market premium (GMP) for the IPO has been going strong for the last few days and showed minor gains when the mainboard issue opened for subscription. This will be of keen interest to private market investors who follow the latest GMP trends, which currently point to positive listing gains for the Rubicon Research IPO.

Here's all you need to kn

See Full Page